Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum

Intralesional injection of collagenase clostridium histolyticum (CCH) improves Peyronie’s disease (PD) symptoms; however, patient perspectives regarding PD and CCH treatment have not been fully elucidated. This cross-sectional qualitative study included heterosexual men with PD who received ≥1 injec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaminetsky, J., Gittelman, M., Kaufman, G. J., Smith, T. M., Jordan, G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760640/
https://www.ncbi.nlm.nih.gov/pubmed/30237548
http://dx.doi.org/10.1038/s41443-018-0027-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760640/
https://www.ncbi.nlm.nih.gov/pubmed/30237548
http://dx.doi.org/10.1038/s41443-018-0027-5

Ejemplares similares